Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Sarcoma”

161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 161 results

Testing effectiveness (Phase 2)Ended earlyNCT05026736
What this trial is testing

Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Who this might be right for
Locally Advanced AngiosarcomaMetastatic AngiosarcomaRecurrent Angiosarcoma
M.D. Anderson Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT02379845
What this trial is testing

NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall

Who this might be right for
Adult Soft Tissue Sarcoma
Nanobiotix 180
Testing effectiveness (Phase 2)Study completedNCT00060944
What this trial is testing

Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Who this might be right for
LiposarcomaLeiomyosarcoma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 271
Early research (Phase 1)Study completedNCT04619056
What this trial is testing

First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma

Who this might be right for
Locally Advanced Soft Tissue SarcomaRecurrent Soft Tissue Sarcoma
CEBIOTEX 21
Testing effectiveness (Phase 2)Ended earlyNCT01059656
What this trial is testing

Phase II Pazopanib Study in Advanced Dermatofibrosarcomas

Who this might be right for
Dermatofibrosarcomas of DARIER FERRAND(DFSP)
Assistance Publique - Hôpitaux de Paris 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03282344
What this trial is testing

NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Who this might be right for
SARCOMA
Memorial Sloan Kettering Cancer Center 88
Testing effectiveness (Phase 2)Looking for participantsNCT04383119
What this trial is testing

Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

Who this might be right for
Leiomyosarcoma of OvarySoft Tissue Sarcoma
Italian Sarcoma Group 100
Early research (Phase 1)Looking for participantsNCT06440005
What this trial is testing

Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Who this might be right for
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc. 80
Early research (Phase 1)WithdrawnNCT00118300
What this trial is testing

Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Not applicableLooking for participantsNCT06211257
What this trial is testing

Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.

Who this might be right for
Sarcoma MetastaticLocally Advanced Soft Tissue Sarcoma
Centre Oscar Lambret 377
Testing effectiveness (Phase 2)Study completedNCT00084630
What this trial is testing

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

Who this might be right for
Adult FibrosarcomaDermatofibrosarcoma ProtuberansRecurrent Adult Soft Tissue Sarcoma+1 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Active Not RecruitingNCT04299113
What this trial is testing

Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma

Who this might be right for
Rhabdomyosarcoma
Jonsson Comprehensive Cancer Center 38
Testing effectiveness (Phase 2)Looking for participantsNCT07153887
What this trial is testing

Vebreltinib for Advanced or Metastatic CCS

Who this might be right for
Clear Cell Sarcoma (CCS)
Second Affiliated Hospital, School of Medicine, Zhejiang University 30
Large-scale testing (Phase 3)Study completedNCT02049905
What this trial is testing

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Who this might be right for
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
ImmunityBio, Inc. 433
Very early researchActive Not RecruitingNCT04634227
What this trial is testing

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

Who this might be right for
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue Sarcoma+2 more
University of Iowa 30
Testing effectiveness (Phase 2)Ended earlyNCT03468075
What this trial is testing

Gemcitabine Plus Ascorbate for Sarcoma in Adults

Who this might be right for
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue Sarcoma+2 more
Mohammed Milhem, MBBS 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Early research (Phase 1)Study completedNCT03761095
What this trial is testing

Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)

Who this might be right for
Leiomyosarcoma
PTC Therapeutics 41
Testing effectiveness (Phase 2)Study completedNCT01281865
What this trial is testing

Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult Synovial SarcomaRecurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue Sarcoma+1 more
National Cancer Institute (NCI) 14
Load More Results